Read More

Nano-Cap Eledon Pharmaceuticals’ Investigational Drug Shows Safety In Early Organ Transplant Study, Analyst Boosts Forecast On Increased Confidence

Eledon Pharmaceuticals' results from islet cell transplant trial for type 1 diabetes, with tegoprubart showing safety and efficacy in kidney transplant patients. Analysts anticipate significant advancements, reflecting in raised price targets.

ELDN

Read More

NeuroSense Announces New Data Analysis From PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing Of Disease Progression In High-Risk ALS Patients; PrimeC Slowed Disease Progression By 43% In Pre-Specified High-Risk ALS Patients

PrimeC slowed disease progression by 43% (p=0.02) in pre-specified high-risk ALS patientsConsistent data across subgroups underscore the potential of PrimeC to redefine the ALS treatment paradigmCAMBRIDGE, Mass., May 7,

NRSN